SCHEMBL19783184

SCHEMBL19783184

COC(=O)COc1cc2sc(N)nc2c(Cl)c1F

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 3/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
GAA P10253 1/20 0.35
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
HMGCR P04035 1/20 0.34
PTGDR Q13258 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
CYP3A4 P08684 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
POLB P06746 1/20 0.34
KCNH2 Q12809 1/20 0.34
HSD17B10 Q99714 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19782970 0.87 LMNA (0.44) LMNAALDH1A1KDM4EKMT2AMAPT
SCHEMBL19783088 0.80 CYP3A4 (0.49) LMNAALDH1A1KDM4EKMT2AMAPT
SCHEMBL19782757 0.74 LMNA (0.39) LMNAALDH1A1KDM4EKMT2AMAPT
SCHEMBL19783689 0.74 LMNA (0.45) LMNAALDH1A1KDM4EKMT2AHPGD
SCHEMBL30189573 0.73 F2RL3 (0.50)
SCHEMBL21379524 0.73 F2RL3 (0.50)
SCHEMBL21379455 0.73 F2RL3 (0.47)
SCHEMBL19783084 0.73 PKM (0.42) ALDH1A1KDM4EMAPTHPGDPTGDR2
SCHEMBL19782974 0.70 ALDH1A1 (0.53) LMNAALDH1A1GAACYP3A4TDP1
Bromide SCHEMBL30189638 0.69 ALDH1A1 (0.51) LMNAALDH1A1GAACYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 LMNA 745/4885ALDH1A1 1618/4885KDM4E 1865/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 LMNA 603/4885ALDH1A1 1598/4885KDM4E 2420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.